Product Information
COLESTIPOL HCL GRANULES is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.2687 per GM under NDC 59762026003. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application before 1982.
Strength
5 g/5g
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762026003
Classification
Generic
Dosage Form
GRANULE, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
COLESTIPOL HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA017563FDA Approved
Before 1982
On Market Since
4/4/1977
Pharmacological Classes
Price Statistics
The NADAC for COLESTIPOL HCL GRANULES has been published 129 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2687 per GM |
|---|---|
| All-time high | $0.2842 (Jun 10, 2026) |
| All-time low | $0.2486 (Mar 19, 2025) |
| 52-week high | $0.2842 |
| 52-week low | $0.2540 |
| Median price | $0.2668 |
| Average price | $0.2658 |
| Largest weekly change | +4.7% (Jun 18, 2025) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Colestipol Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Colestipol Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Bile Acid Sequestrant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of COLESTIPOL HCL GRANULES?
The current National Average Drug Acquisition Cost (NADAC) for COLESTIPOL HCL GRANULES, manufactured by Mylan Pharmaceuticals Inc., is $0.2687 per GM (NDC 59762026003), effective Sep 30, 2026.
How has the price of COLESTIPOL HCL GRANULES changed over time?
Over the history we have for it, the NADAC for COLESTIPOL HCL GRANULES has held within roughly two percent of its current level. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for COLESTIPOL HCL GRANULES?
Since Apr 17, 2024, the NADAC for COLESTIPOL HCL GRANULES has ranged from a low of $0.2486 (Mar 19, 2025) to a high of $0.2842 (Jun 10, 2026), with a median of $0.2668 per GM.
Are there cheaper alternatives to COLESTIPOL HCL GRANULES?
No other NADAC-published product currently shares the active ingredient and strength of COLESTIPOL HCL GRANULES in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures COLESTIPOL HCL GRANULES?
COLESTIPOL HCL GRANULES (NDC 59762026003) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.